Inventor
JAMES MARVIN VEAL
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes20%
C07BGeneral methods of organic chemistry10%
PatentTitleYear
12,172,998Histone demethylase inhibitors202411,987,560Inhibitors of lysine specific demethylase-1202411,884,648Histone demethylase inhibitors202411,679,106Bromodomain inhibitor202311,639,333Histone demethylase inhibitors202311,535,616Histone demethylase inhibitors202211,214,542Histone demethylase inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to CELGENE QUANTICEL RES INC (7)· patent assignee history
2022–2024Based in US· patent location history
2023Patents assigned to QUANTICEL PHARMACEUTICALS INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE QUANTICEL RES INC | 7 | 2022–2024 |
| QUANTICEL PHARMACEUTICALS INC | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 7 | 2022–2024 |